Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 3123
Journal of Alzheimers Disease & Parkinsonism received 3123 citations as per Google Scholar report
Journal of Alzheimers Disease & Parkinsonism peer review process verified at publons
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- China National Knowledge Infrastructure (CNKI)
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Parkinson’s disease: Allogeneic cell replacement therapeutic approach with a novel neural cell line
Joint Event on 5th World Congress on Parkinsons & Huntington Disease & 5th International Conference on Epilepsy & Treatment
Ashok Chakraborty and Anil Diwan
AllExcel, Inc., USA
Posters & Accepted Abstracts: J Alzheimers Dis Parkinsonism
Abstract
Background: Parkinson’s disease is caused by the progressive impairment or deterioration of neurons (nerve cells) in an area of the brain known as Substantia Nigra.Objective: Curative therapy for Parkinson’s disease; Current therapies are based on dopamine supplementation in the brain. They are only palliative, and require adjunct therapies to minimize side effects. Yet long term side effects such as motor neuron defect and Bradykinesia, Dyskinesia etc occur; Cell Replacement Therapy is the only approach that promises functional reversal of Parkinson’s disease.
Methods: AllExcel, Inc. has developed a platform technology for developing designed, functionally improved cell lines without the use of viral vectors or DNA manipulation. Technology is based on concepts derived from naturally observed Human Cell-Cell Interactions (CCITM).
Results: Fast growing potent Dopaminergic cell lines have been produced with long survival in cell culture. In animal studies (6-OHDA treated Rat model for PD), four different clones showed very effective reversal of the disease.
Conclusion: Highly potent modified neural cells have been produced in our lab to treat PD patients.
